Prognostic Heterogeneity in Intermediate-Risk Papillary Thyroid Cancer: Surgery, Radioiodine, and Reclassification Using the 2025ATA Risk Stratification System
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background The 2015 American Thyroid Association (ATA) intermediate-risk category for papillary thyroid carcinoma (PTC) includes patients with heterogeneous outcomes, creating uncertainty regarding surgical extent and postoperative radioactive iodine (RAI). This study evaluated associations of surgical extent and RAI with structural recurrence-free survival (sRFS) and assessed prognostic stratification using the 2025 ATA system. Methods We retrospectively analyzed 454 patients with PTC treated between January 2018 and December 2021 who met the 2015 ATA intermediate-risk criteria. Patients underwent lobectomy without RAI (n = 68), total thyroidectomy without RAI (n = 102), or total thyroidectomy followed by RAI (n = 284). One-to-one propensity score matching (PSM) was performed for lobectomy versus total thyroidectomy and for total thyroidectomy with versus without RAI. All patients were reclassified according to the 2025 ATA system. Results After PSM, sRFS did not differ significantly between lobectomy and total thyroidectomy (P = 0.487) or between total thyroidectomy with and without RAI (P = 0.744). Reclassification assigned 1 patient (0.2%) to low risk, 123 (27.1%) to low-intermediate risk, 322 (70.9%) to intermediate-high risk, and 8 (1.8%) to high risk. Structural event rates were 0%, 12.2%, 17.4%, and 50.0%, respectively, with significant differences across strata (log-rank P = 0.039). Conclusion The 2015 ATA intermediate-risk category showed substantial prognostic heterogeneity. Neither more extensive surgery nor postoperative RAI was associated with improved sRFS after PSM. The 2025 ATA system further separated this population into prognostically distinct groups, although treatment-specific benefits within these strata were not evaluated.
Source: Research Square
Institution: First Hospital of Shanxi Medical University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225894456
